Biopsy Planning System for Prostate Site Management

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biopsy methods, such as saturation biopsy, often result in discomfort and potential organ damage due to the need for multiple biopsy sites, and face challenges in accurately visualizing and managing large numbers of biopsy locations, especially in small organs like the prostate, which can lead to inaccurate results and increased complexity across multiple patient visits.

Innovation Solution

A system and method for managing, planning, and displaying biopsy core sites across multiple patient visits using a computer system associated with medical imaging devices, allowing for the creation of composite images that incorporate previous biopsy plans and data, enabling the selection and navigation of biopsy sites with improved accuracy and reduced clutter during procedures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If saturation biopsy is performed with numerous biopsy sites (90 or more), then the confidence and accuracy of biopsy results is improved, but the patient experiences considerable discomfort and the organ may be damaged

Engineering Contradiction:
Improveconfidence and accuracy of biopsy resultsVSAvoidpatient discomfort and organ damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent divides the saturation biopsy procedure into multiple separate visits, with each visit containing a manageable number of biopsy sites. The system segments the total biopsy plan into phases, allowing the organ to heal between visits while still achieving comprehensive sampling over time.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system performs preliminary planning and visualization of all biopsy sites before the procedure begins. By using 3D imaging and simulation, the operator can identify and mark all target locations in advance, allowing for efficient execution during the actual biopsy procedure.

Inventive Principle:
Principle #10Preliminary action

2Object-affected harmful factors

If the number of biopsy sites is decreased, then patient discomfort and organ damage are reduced, but the probability of accurate results decreases

Engineering Contradiction:
Improvepatient discomfort and organ damageVSAvoidprobability of accurate results
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The system incorporates feedback mechanisms where biopsy results from previous visits inform the planning of subsequent visits. The visualization system updates to show which areas have been sampled and which remain, allowing the operator to adjust the biopsy plan based on actual findings while maintaining comprehensive coverage.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The biopsy plan is made dynamic and adaptable. The system allows the operator to modify the plan between visits based on pathology results, patient condition, and organ healing progress. The visualization system dynamically updates to reflect changes in the biopsy strategy.

Inventive Principle:
Principle #15Dynamics

3Reliability

If a large number of biopsy sites are used, then comprehensive sampling is achieved, but the complexity of managing and navigating to each site increases

Engineering Contradiction:
Improvecomprehensive sampling coverageVSAvoidcomplexity of managing and navigating biopsy sites
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces a computer-based visualization and navigation system as an intermediary between the biopsy plan and the physical procedure. This system serves as a mediator that manages the complexity by providing visual guidance, tracking needle positions, and organizing biopsy sites in a user-friendly interface.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system creates a virtual 3D copy of the organ with all biopsy sites marked on it. This digital replica allows the operator to plan and visualize the entire procedure before execution, reducing the cognitive load during the actual biopsy by referring to the pre-planned virtual model.

Inventive Principle:
Principle #26Copying

4Reliability

If biopsy sites are densely packed in small organs like the prostate, then comprehensive coverage is achieved, but the sites become hard to visualize and manage

Engineering Contradiction:
Improvecomprehensive coverageVSAvoiddifficulty of visualizing and managing dense biopsy sites
Core Design Contradiction:
ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent transitions from 2D imaging to 3D visualization to represent biopsy sites in small organs. By adding the third dimension, the system can display densely packed sites in spatial context, showing their depth and relationship to organ structures, making them easier to distinguish and manage despite high density.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS7942829B2Biopsy planning and display apparatus
Publication Date: 2011.05.17 EIGEN HEALTH SERVICES LLC
  • US7942829B2 patent drawing
  • US7942829B2 patent drawing
  • US7942829B2 patent drawing

AI summary

Systems are provided for managing, planning and displaying the location of biopsy core sites across multiple same-patient visits or other stored biopsy plans to increase the confidence and accuracy of biopsy results. The systems may allow the operator to fuse multiple predefined and/or automatically generated biopsy core site plans in addition to previous biopsy sites with a current prostate image to assist in creating a final new biopsy core site plan. Further, the system may allow the operator to selectively view singular parts of the final plan to simplify the planning process. Further, the systems may assist the operator during the navigation phase of the biopsy by hiding biopsy core sites from the final plan that are not of immediate interest during the biopsy phase and thereby reducing clutter and distraction during biopsy sample acquisition.